<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html>

<head>
  <meta http-equiv="content-type" content="text/html; charset=utf-8" />
<style type="text/css"></style>
<meta http-equiv="Content-Type" content="text/html; charset=gb2312"/> 
        <style type="text/css">         
               @page {margin:1in 1in 0.5in 1in}

                .style1
                {
                        font-family:Arial;
                        font-size:13px;
                }

pre {
 white-space: pre-wrap;       /* css-3 */
 white-space: -moz-pre-wrap;  /* Mozilla, since 1999 */
 white-space: -pre-wrap;      /* Opera 4-6 */
 white-space: -o-pre-wrap;    /* Opera 7 */
 white-space: pre-line;
 word-wrap: break-word;       /* Internet Explorer 5.5+ */
}

        </style>
</head><body>

<table border="0" style="width:600px; BORDER-COLLAPSE: collapse;">
  <tr>
    <td align="center" valign="middle"><img src="https://ebridge.xjtlu.edu.cn/jiaotong_files/logo.gif"/>
    </td>
  </tr>
</table>

<p > <b>MODULE SPECIFICATION</b></p>
<br/>

		<table border="1" style="width: 600px; BORDER-COLLAPSE: collapse;">
            <tr>
                <td width=50% bgcolor="#ADD8E6"><b>Module Title</b> </td>
                <td width=50%>Biology of Disease </td>
            </tr>
            <tr>
                <td bgcolor="#ADD8E6"><b>Module Code</b></td>	
                <td>BIO301</td>
            </tr>
            <tr>
                <td bgcolor="#ADD8E6"><b>Originating Department/School</b></td>
                <td>Department of Biological Sciences</td>
            </tr>
            <tr>
                <td bgcolor="#ADD8E6"> <b>Module Level<sup>1</sup></b> </td>
                <td> 3  ( FHEQ level 6 )</td>
            </tr>
            <tr> 
                <td bgcolor="#ADD8E6"><b>Module Credits</b>&nbsp;<em>(normally 5)</em></td>
                <td>5</td>
            </tr>
            <tr> 
                <td bgcolor="#ADD8E6"><b>Pre-requisites</b>&nbsp;<em>(including Year 1)</em></td>
                 <td>BIO103 <br>BIO107 <br>BIO201 <br>BIO208 <br></td>
            </tr>
            <tr> 
                <td bgcolor="#ADD8E6"><b>Shared Programme(s)</b>&nbsp;<em>(please name all)</em></td>
                <td>
BSc Biological Sciences</p>
</td>
            </tr>
        </table>


	<p>	<b>Mode of Delivery and Hours</b>	</p>	
		<table border="1" style="width: 600px; BORDER-COLLAPSE: collapse;">		
			<tr>
				<td bgcolor="#ADD8E6">&nbsp; &nbsp;</td>
				<td bgcolor="#ADD8E6"><b>Lectures</b></td>
				<td bgcolor="#ADD8E6"><b>Seminars</b></td>
				<td bgcolor="#ADD8E6"><b>Tutorials</b></td>
				<td bgcolor="#ADD8E6"><b>Lab / Practicals</b></td>
				<td bgcolor="#ADD8E6"><b>Fieldwork / Placement</b></td>
				<td bgcolor="#ADD8E6"><b>Other</b> <em>(Private study)</em></td>
				<td bgcolor="#ADD8E6"><b>Total</b></td>
			</tr>
			
			<tr>
				<td bgcolor="#ADD8E6"><b>Hours / Semester</b></td>
				<td>26</td>
				<td></td>
				<td>10</td>
				<td></td>
				<td></td>
				<td>114</td>
				<td>150</td>
			</tr>
			
			<tr>
				<td bgcolor="#ADD8E6"><b>Delivery Pattern</b></td>
				<td>13*2</td>
				<td></td>
				<td>10*1</td>
				<td></td>
				<td></td>
				<td></td>
				<td></td>
			</tr>					
		</table>
		

               	
         	<p>	  <b>Description</b> </p>
        <table border="1" style="width: 600px; text-align: left; BORDER-COLLAPSE: collapse;">
            <tr><td bgcolor="#ADD8E6"><b>Aims and Fit of Module</b><em>(i.e. relationship to programme)</em></td></tr>			
			<tr><td><pre>This module will examine the molecular and biochemical processes that underlie a number of important human diseases. These diseases include common inherited diseases, diabetes, cardiovascular/neurological disorders and diseases of lipid metabolism, e.g. heart disease/stroke, atherosclerosis and obesity. 
The module will also allow the student to study critically the role of oncogenes and tumour suppressor genes in the development of human cancer, including their identification, followed by a general discussion of human cancer as a disease from the pathological and molecular biological viewpoints including concepts of progression and metastasis. 

</pre></td> </tr>

			<tr><td bgcolor="#ADD8E6"><b>Learning Outcomes</b><em>(for accreditation and other reasons,sub-headings could be added to this section)<br/>Students completing the module successfully should be able to:</em></td></tr>		
			<tr><td><pre>A. Define how metabolic disorders can lead to diabetes and hypertension.
B. Illustrate how protein defects can lead to genetic diseases, heart failure and neurological diseases.
C. Interpret how problems in lipid metabolism cause disease and define the associated treatments.
D. Define concepts of progression from normal to cancerous states and the classify the associated progression mechanisms.
E. Recognise experimental systems used to decipher  principles of development of human diseases, cancer and how they can be applied to solve problems in this area.
</pre></td> </tr>

			<tr><td bgcolor="#ADD8E6"><b>Method of Teaching and Learning</b></td></tr>	
			<tr><td><pre>Course content will be delivered primarily via standard lectures and tutorials that will be accompanied by suitable lecture handouts. Students will also be guided to sections of specific textbooks and/or reading of specific reviews.</pre></td></tr>

			<tr><td bgcolor="#ADD8E6"><b>Syllabus</b></td></tr>	
			<tr><td><pre>Topic 1 	Molecular foundations of monogenetic diseases. 
Topic 2 	Metabolic disorders. Diabetes.
Topic 3 	Obesity and energy homeostasis.
Topic 4 	Cardiovascular disorders. Hypertension. Renin, angiotensin, aldosterone, ACE, ACE inhibitors, angiotensin receptors. 
Topic 5 	Cardiomyopathies. Cardiac hypertrophy and dilated cardiomyopathy.
Topic 6	Neurological disorders. Post-translational modification of proteins and diseases. Prions and TSEs. 
Topic 7 	Neurological disorders: Alzheimer's disease.  
Topic 8	Introduction and overview. Diversity of lipids and lipid-related disease: Cholesterol and coronary heart disease/stroke; the steroid hormones; eicosanoids in inflammatory disease and sphingolipids. 
Topic 9 	Cholesterol: A central lipid in health and disease. Synthesis and regulation of cholesterol.
Topic 10 	Lipid trafficking in the body. Lipoproteins, defects in lipoprotein metabolism and dyslipidemias. 
Topic 11 	Abnormalities in lipid metabolism and the disease mechanisms of atherosclerosis.
Topic 12	Sphingolipids and disease. 
Topic 13       Introduction of cancer and the hallmarks of cancer
Topic 14       Tumour viruses
Topic 15       Oncogenes 
Topic 16       Growth factors and their receptors.
Topic 17       Regulation of cell growth


Topic 18       Anti-oncogenes and tumour suppressor genes
Topic 19       Genomic stability and cancer (DNA damage, repair and cancer)
 Topic 20       p53 and apoptosis
 Topic 21       Tumour angiogenesis and metastasis.
Topic 22       Stem cells and differentiation. Hormones and cancer. Animal models of cancer. 
</pre></td> </tr>
        </table>	


			<p>	<b>Assessment</b><br><br>
<i><font style="color:red">The Assessment Method for midterm and final exams may change in response to<br> the situation of the pandemic control, and details should be sought from module leaders.</font></i></p>
		<em>Initial Assessment</em>
     <table border="1" style="width: 600px; text-align: center; BORDER-COLLAPSE: collapse;">
			<tr>
				<td bgcolor="#ADD8E6"><b>Sequence</b></td>
				<td bgcolor="#ADD8E6"><b>Method</b></td>
                                           <td bgcolor="#ADD8E6"><b>Assessment Type(EXAM or CW)<sup>2</sup></b></td>
				<td bgcolor="#ADD8E6"><b>Learning outcomes assessed</b><em>(use codes under Learning Outcomes)</em></td>	
				<td bgcolor="#ADD8E6"><b>Duration</b></td>
                                            <td bgcolor="#ADD8E6"><b>Week</b></td>				
				<td bgcolor="#ADD8E6"><b>% of Final Mark</b></td>
				<td bgcolor="#ADD8E6"><b>Resit(Y/N/S)<sup>3</sup></b></td>
			</tr>
					
            <tr>
				<td>001</td>
				<td>Final Exam</td>
				<td>EXAM</td>
				<td>A-E</td>
				<td>3 hours</td>	
				<td></td>	
				<td>85</td>
                                             <td>N</td>
			</tr>	
					
            <tr>
				<td>002</td>
				<td>Continuous</td>
				<td>CW</td>
				<td>A-E</td>
				<td></td>	
				<td></td>	
				<td>15</td>
                                             <td>N</td>
			</tr>	
			
	 </table>

	<em>Resit Assessment</em>
     <table border="1" style="width: 600px; text-align: left; BORDER-COLLAPSE: collapse;">
			<tr>
                <td bgcolor="#ADD8E6"><b>Sequence</b></td>
                <td bgcolor="#ADD8E6"><b>Assessment Type<br/>(EXAM or CW)</b></td>
				<td bgcolor="#ADD8E6"><b>Learning outcomes assessed</b><em><br/>(use codes under Learning Outcomes)</em></td>	
				<td bgcolor="#ADD8E6"><b>Duration</b></td>
                <td bgcolor="#ADD8E6"><b>Week</b></td>				
				<td bgcolor="#ADD8E6"><b>% of Final Mark</b></td>
			</tr>
			

			
	 </table>

		 <table border="0" style="width: 600px; text-align: left; BORDER-COLLAPSE: collapse;">

			<tr><td  class="style1">Reassessment opportunities in the same academic year are not available for final year undergraduate students. Any students eligible to be reassessed in a failed Year 4 (Level 3) module will have the resit opportunity at the next ordinary sitting of the examination/assessment</td></tr>

		 </table>
		

			<p>	<b>Textbooks</b><sup>4</sup></p>
                                <em>Mandatory Textbooks</em>
		<table border="1" style="width: 600px; text-align: left; BORDER-COLLAPSE: collapse;">
			<tr>
				<th style="width: 300px; text-align: left;" bgcolor="#ADD8E6">Title</th>
				<th style="width: 150px; text-align: left;" bgcolor="#ADD8E6">Author</th>
				<th style="width: 150px; text-align: left;" bgcolor="#ADD8E6">ISBN/Publisher</th>
			</tr>				
				
			 	
		</table>

                                <em>Optional Textbooks</em>
		<table border="1" style="width: 600px; text-align: left; BORDER-COLLAPSE: collapse;">
			<tr>
				<th style="width: 300px; text-align: left;" bgcolor="#ADD8E6">Title</th>
				<th style="width: 150px; text-align: left;" bgcolor="#ADD8E6">Author</th>
				<th style="width: 150px; text-align: left;" bgcolor="#ADD8E6">ISBN/Publisher</th>
			</tr>
			
			
			
		</table>

                                <em>Reference Textbooks</em>
		<table border="1" style="width: 600px; text-align: left; BORDER-COLLAPSE: collapse; ">
			<tr>
				<th style="width: 300px; text-align: left;" bgcolor="#ADD8E6">Title</th>
				<th style="width: 150px; text-align: left;" bgcolor="#ADD8E6">Author</th>
				<th style="width: 150px; text-align: left;" bgcolor="#ADD8E6">ISBN/Publisher</th>
			</tr>
			
			
			

			<tr>
				<td style="font-size:13px;">BIOCHEMISTRY (2015) 8TH EDITION.</td>
				<td style="font-size:13px;">BERG JM, TYMOCZKO JL AND STRYER L</td>
				<td style="font-size:13px;">9781464126109 /W.H. FREEMAN & COMPANY</td>
			</tr>
			

			<tr>
				<td style="font-size:13px;">CLINICAL BIOCHEMISTRY METABOLIC AND CLINICAL ASPECTS (2014, 3RD ED)</td>
				<td style="font-size:13px;">MARSHALL WJ, LAPSLEY M, DAY AP AND AYLING RM</td>
				<td style="font-size:13px;">9780702051401 /ELSEVIER</td>
			</tr>
			

			<tr>
				<td style="font-size:13px;">MOLECULAR BIOLOGY OF CANCER: MECHANISMS, TARGETS, AND THERAPEUTICS (2012, 3RD ED)</td>
				<td style="font-size:13px;">LAUREN PECORINO</td>
				<td style="font-size:13px;">9780199577170 /OXFORD UNIVERSITY PRESS</td>
			</tr>
			

			<tr>
				<td style="font-size:13px;">THE BIOLOGY OF CANCER (2014, 2ND ED)</td>
				<td style="font-size:13px;">WEINBERG RA</td>
				<td style="font-size:13px;">9780815342205 /GARLAND SCIENCE</td>
			</tr>
			

			<tr>
				<td style="font-size:13px;">MOLECULAR BIOLOGY OF THE CELLS (2014: 6TH ED)</td>
				<td style="font-size:13px;">ALBERTS B ET. AL</td>
				<td style="font-size:13px;">9780815344322 /GARLAND SCIENCE</td>
			</tr>
			
		</table>

<table border="0" style="width: 600px; text-align: left; BORDER-COLLAPSE: collapse;">
<tr><td align="left">&nbsp;</td></tr>
<tr><td align="left"><hr width="30%" align="left"></td></tr>
<tr>
<td class="style1"><sup>1</sup>Undergraduate programmes Year 1/Level 0 is equivalent to FHEQ Level 3, Year 2/Level 1 is equivalent to FHEQ Level 4, Year 3/Level 2 is equivalent to FHEQ Level 5, Year 4/Level 3 is equivalent to FHEQ Level 6, and Master programme Level 4 is equivalent to FHEQ Level 7.  FHEQ stands for “The Frameworks for HE Qualifications of UK Degree-Awarding Bodies”. It applies to degrees, diplomas, certificates and other academic awards (other than honorary degrees and higher doctorates) granted by a higher education provider in the exercise of its degree awarding powers. FHEQ is an important reference point for providers of higher education. These are numbered 4-8, succeeding levels 1-3 which precede higher education in “The National Qualifications Framework and The Qualifications and Credit Framework (NQF/QCF)”.  For more information please refer to: <a href='https://www.qaa.ac.uk/quality-code/qualifications-and-credit-frameworks'>https://www.qaa.ac.uk/quality-code/qualifications-and-credit-frameworks</a>.</td>
</tr>
<tr>
<td class="style1"><sup>2</sup>Examination (EXAM) is an assessment task formally scheduled and supervised by the University which takes place over a specified period, in a specified location and at a specified time, e.g. mid-term, final, resit etc. Coursework or continuously assessed work (CW) is different than EXAM; it is undertaken throughout the semester organized by the department.</td>
</tr>
<tr>
<td class="style1"><sup>3</sup>“Y” means that the corresponding resit is an independent assessment covering the same learning outcomes, in the same assessment type and bearing the same weighting with the original assessment; “N” means there is no resit opportunity for the particular component; “S” means there will be a single resit that will be designed to assess all learning outcomes of the module, and will be weighted as 100% of the final module mark, disregarding any marks achieved at the original assessment.</td>
</tr>
<td class="style1"><sup>4</sup>Mandatory: every student will be charged for a copy of the text, whether or not they collect it<br>
Optional: the Library will purchase a number of copies for students to purchase if they wish<br>
Reference: the Library will add a couple of copies to their collection<br>
Textbooks are subject to change until the final procurement complete.
</td>
</tr>
</table>


<br>

</body>

</html>